[Clinical research in Europe and its impact on cancerology--problems and opportunities].
Breakthroughs in molecular biology open new ways forward in therapeutics and subsequently unique opportunities for Europe. Clinical research in oncology is multidisciplinary and very complex. Two distinct objectives should be put forward: 1. To develop, register and market innovative molecules. 2. To develop standard therapeutic strategies. The harmonization of European legislations on clinical trials and financial support to studies conducted without commercial aim pose a major challenge for Europe. Europe should promote clinical research that fosters synergies between universities, healthcare centres and pharmaceutical industry on one hand and public authorities funding healthcare on the other hand, for the best benefit of all patients.